Starlight Ventures

Starlight Ventures Management LLC is a venture capital firm established in 2017 and headquartered in Miami, Florida. The firm specializes in early-stage investments, focusing on innovative companies that leverage science and technology to tackle significant global challenges. Starlight Ventures targets various sectors, including biotechnology, synthetic biology, sustainable production, healthspan, longevity, diagnostics, therapeutics, genetics, AG-tech, and bio-fabrication. Additionally, it invests in emerging fields such as space technology, energy transition, machine learning, big data, and quantum computing. With a global investment approach, Starlight Ventures aims to support visionary entrepreneurs who are poised to make a meaningful impact across these diverse industries.

Matias Mosse

Co-Founder & Managing Partner

37 past transactions

Keel Labs

Series A in 2022
Keel Labs, formerly known as AlgiKnit Inc., is a biomaterials company focused on developing sustainable materials for the textile industry. Founded in 2017 and based in New York, the company specializes in producing yarn spun from kelp and converting seaweed into fiber. By integrating scientific innovation with design, Keel Labs aims to create environmentally friendly alternatives to traditional textile materials, addressing the growing demand for sustainability in fashion and textile production.

Impossible Metals

Seed Round in 2022
Developer of underwater robotics vehicle designed to collect battery metals from the seabed without harming the environment. The company's robot collects nodules individually using multiple high-speed manipulators and staying buoyant above the seafloor, enabling clients to easily conduct seabed harvesting without destroying the habitat.

Quaise

Series A in 2022
Quaise is an energy company pioneering millimeter wave drilling technology to access deep geothermal energy. Quaise is developing and commercializing novel millimeter wave drilling systems to harness geothermal energy around the globe, overcoming the geographic constraints limiting this energy source today.

Modern Hydrogen

Series B in 2021
Modern Hydrogen is an innovative energy technology company focused on producing clean hydrogen through a distributed production system. By transforming the heat generated from industrial and commercial boilers and furnaces into usable power, the company effectively reduces energy waste and carbon emissions. This on-site hydrogen production not only helps clients save money but also enhances their resilience during power outages. Modern Hydrogen's mission is to deliver affordable electricity, making energy accessible to a wider audience while contributing to a sustainable future.

Commonwealth Fusion

Series B in 2021
Commonwealth Fusion Systems LLC is a research company focused on developing fusion energy as a sustainable solution to combat climate change. Established in 2017 and based in Cambridge, Massachusetts, the company utilizes advanced rare-earth barium copper oxide superconductor technology to create energy through fusion. Commonwealth Fusion Systems combines decades of government-funded fusion research with innovative superconducting magnet technology to expedite the commercialization of fusion energy. The company emerged from the Massachusetts Institute of Technology and collaborates closely with MIT’s Plasma Science and Fusion Center, leveraging extensive research to enhance its development efforts. By designing and building fusion machines, Commonwealth Fusion aims to provide limitless and clean energy, contributing to the global transition toward sustainable energy sources.

Tynt Technologies

Seed Round in 2021
Tynt Technologies is a developer of a smart window to prevent glare while maintaining views and save energy. It offers ideal visual and thermal occupant comfort while minimizing building energy consumption from lighting and HVAC use. The company was founded in 2020 and is headquartered in Boulder, Colorado.

Holy Grail

Seed Round in 2021
Holy Grail.Ai Limited, founded in 2019 and based in London, United Kingdom, specializes in the manufacturing of batteries for various sectors, including mobility, electronics, and utilities. The company employs machine learning techniques to enhance battery research, focusing on areas such as battery storage and catalysts. A team of scientists, engineers, and designers drives the company's mission to innovate and address significant challenges in material science and chemistry.

ZELP

Series A in 2021
ZELP Ltd. is a London-based company established in 2017 that specializes in manufacturing a wearable device designed to reduce ethane emissions in livestock. The company's innovative technology aims to mitigate the environmental impact associated with the livestock industry, addressing concerns related to greenhouse gas emissions and sustainability. By focusing on this niche sector, ZELP is contributing to efforts aimed at promoting more environmentally friendly practices within agriculture.

Inner Cosmos

Venture Round in 2020
Inner Cosmos LLC develops an invasive device, a brain-computer interface to treat mood disorder. The company manufactures digital pill, a device that rebalances brain networks using electrical activity. Inner Cosmos LLC was incorporated in 2016 and is based in New Haven, Connecticut.

Commonwealth Fusion

Series A in 2020
Commonwealth Fusion Systems LLC is a research company focused on developing fusion energy as a sustainable solution to combat climate change. Established in 2017 and based in Cambridge, Massachusetts, the company utilizes advanced rare-earth barium copper oxide superconductor technology to create energy through fusion. Commonwealth Fusion Systems combines decades of government-funded fusion research with innovative superconducting magnet technology to expedite the commercialization of fusion energy. The company emerged from the Massachusetts Institute of Technology and collaborates closely with MIT’s Plasma Science and Fusion Center, leveraging extensive research to enhance its development efforts. By designing and building fusion machines, Commonwealth Fusion aims to provide limitless and clean energy, contributing to the global transition toward sustainable energy sources.

HelixNano

Convertible Note in 2020
Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases. HelixNano is a Y Combinator and venture backed biotech startup. At HelixNano, we have spent the last two years developing cancer vaccines. Now we are adapting our synthetic biology arsenal to take on COVID-19. We’re moving fast but thinking long-term. We’re already testing COVID-19 vaccine candidates designed to be precise and safe. Our next goal is to create a vaccine that protects everyone not only from this virus, but all future coronaviruses.

Commonwealth Fusion

Series A in 2019
Commonwealth Fusion Systems LLC is a research company focused on developing fusion energy as a sustainable solution to combat climate change. Established in 2017 and based in Cambridge, Massachusetts, the company utilizes advanced rare-earth barium copper oxide superconductor technology to create energy through fusion. Commonwealth Fusion Systems combines decades of government-funded fusion research with innovative superconducting magnet technology to expedite the commercialization of fusion energy. The company emerged from the Massachusetts Institute of Technology and collaborates closely with MIT’s Plasma Science and Fusion Center, leveraging extensive research to enhance its development efforts. By designing and building fusion machines, Commonwealth Fusion aims to provide limitless and clean energy, contributing to the global transition toward sustainable energy sources.

Carbon Engineering

Private Equity Round in 2019
Carbon Engineering Ltd. is a Canadian clean energy company established in 2009, headquartered in Squamish, British Columbia. The company specializes in developing and commercializing technology that captures carbon dioxide (CO2) directly from the atmosphere. Its innovative chemical-based CO2 air capture system allows large facilities to address emissions from various sources, facilitating the management of emissions associated with vehicles, airplanes, and buildings. Carbon Engineering's technology includes an air contactor and a regeneration cycle that enables continuous capture of atmospheric CO2 and the production of pure carbon dioxide. Since 2015, the company has been actively removing CO2 from the atmosphere, and as of December 2017, it has also been synthesizing this captured carbon into clean, affordable transportation fuels.

Carbon Engineering

Series A in 2019
Carbon Engineering Ltd. is a Canadian clean energy company established in 2009, headquartered in Squamish, British Columbia. The company specializes in developing and commercializing technology that captures carbon dioxide (CO2) directly from the atmosphere. Its innovative chemical-based CO2 air capture system allows large facilities to address emissions from various sources, facilitating the management of emissions associated with vehicles, airplanes, and buildings. Carbon Engineering's technology includes an air contactor and a regeneration cycle that enables continuous capture of atmospheric CO2 and the production of pure carbon dioxide. Since 2015, the company has been actively removing CO2 from the atmosphere, and as of December 2017, it has also been synthesizing this captured carbon into clean, affordable transportation fuels.

Geltor

Series A in 2018
Geltor, Inc. produces bioactive animal free collagens and other proteins for beauty, nutrition, and other applications. It offers Collume, a bio-designed collagen technology for skincare cellular regeneration, protection, and derma-collagen synthesis; and HumaColl21, a collagen product that delivers collagen, elastin, laminin, and fibronectin boosting effect for skin care. The company also provides vegan collagen peptides and other novel proteins for functional food and nutraceutical formulas. Geltor, Inc. was incorporated in 2015 and is based in San Leandro, California.

Openwater

Seed Round in 2018
Openwater designs and develops MRI-resolution wearables that medical diagnoses and treatments, and a new era of fluid and affordable brain-to-computer communications to consumer electronics manufacturing facilities and techniques. The company was founded in 2016 and is based in San Francisco, California.

Made In Space

Seed Round in 2018
Made In Space, Inc. specializes in the design and manufacture of equipment for space exploration, national security, and sustainable space settlement. Founded in 2010 and headquartered in Jacksonville, Florida, the company develops a range of products including space-optimized structures, space telescopes, and equipment for additive manufacturing and recycling in space. Made In Space focuses on advanced technologies that support on-orbit manufacturing and aims to address the challenges of future space missions. As of June 2020, it operates as a subsidiary of Redwire, which provides mission-critical solutions and components for the evolving space economy.

Good Catch

Series A in 2018
Good Catch Foods focuses on creating vegan and plant-based substitutes for seafood. Founded in 2016, the company offers a variety of products including plant-based shredded tuna, crab cakes, and fish patties, all made from ingredients such as pea proteins, lentils, chickpeas, and fava beans. Originally based in New York, Good Catch has since moved its headquarters to Newtown, Pennsylvania, where it continues to innovate in the field of plant-based seafood alternatives.

Catalog

Seed Round in 2018
CATALOG is a developer of a data conversion and storage platform used to offer the next generation of digital data archives and computation. Its platform facilitates the encoding of data and information into DNA format and makes it economically attractive to use DNA as the major medium for long-term archival of data that enables customers to store digital information in DNA molecules. It brings cutting-edge synthetic biology technologies to the world of information storage and computation. The company was founded in 2016 and is headquartered in Boston, Massachusetts.

Emulate

Series C in 2018
Emulate, Inc. specializes in organs-on-chips technology designed to mimic human biology, enabling a better understanding of how diseases, medications, chemicals, and food impact human health. The company offers organ-chips that replicate the functions and disease states of various human organs, including the lung, intestine, liver, and skin. In addition to its organ-chips, Emulate provides software applications for drug development and research workflows, catering to a diverse clientele that includes biotechnology and pharmaceutical companies, consumer health and cosmetics industries, agricultural firms, and academic researchers. Founded in 2013 and based in Boston, Massachusetts, Emulate aims to set a new standard for accurately predicting human responses across multiple fields, including drug development and personalized medicine. The company was previously known as Emulate Living MicroDevices, Inc. before rebranding in 2014.

Skyloom Global

Seed Round in 2018
Skyloom Global Corp. develops and manufactures outer space communication technology for creating a space-borne infrastructure. The company offers optical communications based products and relay satellites placed in geostationary orbit. It products help in increasing space-to-earth bandwidth. The company was founded in 2017 and is based in Merritt Island, Florida.

Carbo Culture

Seed Round in 2018
Carbo Culture Oy is a Finnish company that specializes in producing biochar from biomass waste, utilizing a carbon sequestration process to capture carbon dioxide from the atmosphere. Founded in 2016 and based in Helsinki, the company focuses on upcycling orchard waste into stable, solid biocarbon products. These products serve various applications, including soil remediation and enhancing soil properties by improving water retention and nutrient availability. Carbo Culture's biochar acts as a long-term solution for repairing damaged soils and mitigating crop losses while preventing carbon from re-entering the atmosphere for centuries. The company's innovative approach reflects its commitment to sustainable practices and environmental responsibility.

HelixNano

Convertible Note in 2018
Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases. HelixNano is a Y Combinator and venture backed biotech startup. At HelixNano, we have spent the last two years developing cancer vaccines. Now we are adapting our synthetic biology arsenal to take on COVID-19. We’re moving fast but thinking long-term. We’re already testing COVID-19 vaccine candidates designed to be precise and safe. Our next goal is to create a vaccine that protects everyone not only from this virus, but all future coronaviruses.

SuperMeat

Seed Round in 2018
SuperMeat is an Israeli bio-tech and food-tech company, developing a technology to create clean meat from chicken cells in a safe and controlled environment, external to the animal’s body. SuperMeat is set to revolutionize the meat industry from its core, aspiring to secure a better future for humans and animals alike. Clean meat is grown in a controlled, sterile environment without the use of antibiotics and without any possibility of fecal contamination, such as salmonella. Clean meat will require significantly less resources for its production (99% less land, 90% less water), making it both a healthy and sustainable food source for the coming century.

SpinLaunch

Convertible Note in 2017
SpinLaunch Inc., a spaceflight technology development company, focuses on the development of an alternative launch system that uses a large mass accelerator to hurl payloads to space. It builds a kinetic space launch system that allows for on-demand launches of small satellites in any weather. The company was incorporated in 2014 and is based in Long Beach, California.

Locus Biosciences

Series A in 2017
Locus Biosciences is a developer of a CRISPR-engineered precision antibacterial platform designed to revolutionize the treatment of bacterial disease. The company's platform combines the antibacterial power of CRISPR-Cas3 with the efficient, safe delivery of bacterial viruses called bacteriophage, enabling physicians to begin treatment more quickly, resulting in a better medical outcome.

OpenZeppelin

Seed Round in 2017
OpenZeppelin builds developer tools and performs security audits for distributed systems that power multimillion-dollar economies. At OpenZeppelin, we have built the world’s leading Open Source library for smart contract development. OpenZeppelin Contracts powers over 3,000 public projects, with over 7,000 stars on Github and maintained by a community of 180+ contributors. We also conduct security audits for the Ethereum Foundation, Coinbase, and other leading organizations in the space. With the success of our product, our security audits work, and our educational efforts, we have set industry standards for building secure systems in a fast-growing industry. We are now excited to offer a development platform that will help the growing number of developers working on top of decentralized protocols build the applications that will reach mass adoption.

3T Biosciences

Seed Round in 2017
3T Biosciences, Inc. offers immunotherapies for cancer. The company was founded in 2017 and is based in Palo Alto, California.

ICEYE

Series A in 2017
ICEYE Oy provides real-time access to imagery through optical imaging technology. It enables users to monitor illegal fishing, oil spills, storm damage, and forest growth; monitor crops growth, storm damages, and pest movements; map other planets for resources and ensure exploration safety; monitor flood damage, receive real-time mapping for aid activities, and conduct maritine search and rescue; and monitor port or storage activity, monitor sea ice and icebergs, track pirate vessels, and view highway activity. The company was founded in 2014 and is based in Espoo, Finland.

Catalog

Seed Round in 2017
CATALOG is a developer of a data conversion and storage platform used to offer the next generation of digital data archives and computation. Its platform facilitates the encoding of data and information into DNA format and makes it economically attractive to use DNA as the major medium for long-term archival of data that enables customers to store digital information in DNA molecules. It brings cutting-edge synthetic biology technologies to the world of information storage and computation. The company was founded in 2016 and is headquartered in Boston, Massachusetts.

Finless Foods

Convertible Note in 2017
Finless Foods Inc. is a biotechnology company based in Emeryville, California, focused on producing sustainable seafood alternatives through cellular agriculture technologies. Founded in 2017, the company specializes in growing marine-animal cells to create seafood products, including bluefin tuna. Finless Foods aims to provide a healthier and environmentally friendly alternative to traditionally caught and farmed seafood, offering consumers a cost-effective option that does not compromise on taste or dietary preferences. The company's mission is to develop and mass manufacture innovative marine animal food products that promote sustainability and accessibility in the seafood market.

uBiome

Venture Round in 2014
uBiome, Inc. is a microbial genomics company based in San Francisco, California, founded in 2012. The company specializes in developing sequencing-based clinical microbiome tests, which include SmartGut, a test that identifies pathogenic and commensal microorganisms linked to infections, and SmartJane, a women's health screening test that assesses multiple conditions such as HPV and STIs. Additionally, uBiome offers Explorer kits for citizen scientists and researchers, as well as SmartFlu, a clinical respiratory test. The firm aimed to empower patients and healthcare providers by providing insights into the human microbiome and its impact on health. However, uBiome faced financial difficulties, filing for Chapter 11 bankruptcy in September 2019, which was subsequently converted to Chapter 7 on October 11, 2019.

Modern Meadow

Seed Round in 2013
Modern Meadow, LLC is a biofabrication company established in 2011 and headquartered in Brooklyn, New York. The company specializes in producing animal-free leather and other cultured products, such as meat alternatives, through innovative methods that eliminate the need for animal slaughter. By utilizing living cells and fermentation-based processes, Modern Meadow develops lightweight materials that provide superior color, performance, and durability, while also promoting lab-to-brand traceability. Their approach significantly reduces the inputs of land, water, energy, and chemicals, contributing to lower greenhouse gas emissions. This focus on sustainability enables customers to maintain the quality and appearance of materials without relying on petrochemical inputs or animal-derived substances.

Satellogic

Seed Round in 2013
Satellogic specializes in the development and operation of nano satellites for commercial-grade Earth observation, providing real-time data streams that support decision-making for governments, organizations, and businesses. Founded in 2010 and based in Palo Alto, California, the company has created a scalable Earth observation platform capable of remapping the entire planet with high frequency and resolution. Its low-Earth-orbit satellite constellation enables a wide range of applications, including agriculture, pipeline monitoring, critical infrastructure oversight, disaster response, illegal logging detection, border patrol, and port security. Satellogic serves a global customer base, with significant revenue generated from the Asia Pacific region, and operates across North America, Europe, and South America.

Stereobot

Seed Round in 2013
Stereobot specializes in developing 3D building and visualization systems. Stereobot was founded in 2012 and is based in Los Angeles, California.

inui Health

Seed Round in 2011
inui Health is a consumer medical diagnostics company based in Silicon Valley. Their vision is to make medical-grade information accessible anytime, anywhere. Their cloud-based diagnostic platform works in a mobile environment to empower consumers with access to their own health information. Their products will help consumers detect complications early, monitor their health, and easily share their health information so they can work with their healthcare provider for timely interventions. The first product to be released will be the inui In-Home Urine Analysis test system, which provides patients and physicians with immediate lab test results.